Global Bioenergies Expands Isobutene Plant Plans in France

Key highlights
  • The new plant will produce 10,000 tonnes of isobutene annually.
  • First-half revenue totaled €2.4 million.
  • The plant is scheduled to come on stream at the end of 2027.
  • Design and construction schedules will be released by the end of 2023.
Related project For subscribers
Milestones, plant data, involved companies (owners, investors, licensors, contractors) and news — kept up to date.
Global Bioenergies bio-isobutene plant, France (site undecided)
Cancelled
2023
2024-10-17

Project Expansion

Global Bioenergies has announced plans to increase the production capacity of its upcoming isobutene plant in France. The new facility will produce 10,000 tonnes of isobutene and derivatives annually, a significant increase from the previously planned 2,000 tonnes. This expansion aims to meet the growing demands of industrial, commercial, and financial partners.

Market Focus

The plant will primarily target the cosmetics market, with future plans to supply the sustainable aviation fuel market. Global Bioenergies has recently obtained ASTM certification, which is crucial for entering the aviation fuel sector.

Financial Performance

In the first half of the year, Global Bioenergies reported revenue of €2.4 million. Despite generating sales, the commercial activities of the Pomacle unit have been deprioritized due to low associated margins. The company is now focusing its efforts on the new plant, which is scheduled to come on stream by the end of 2027.

Future Plans

Global Bioenergies is also exploring the deployment of its technology in other regions and with different feedstocks, in collaboration with international industrial groups. The design and construction schedules for the new plant will be released by the end of 2023.

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time. See our Privacy Policy.

Related articles

4 November 2025
Global Bioenergies Takeover Review Postponed to 24 November

Review hearing postponed; new offer deadline 12 November. Possible asset takeover or liquidation could lead to delisting. Financial statements delayed due to process uncertainty.

29 September 2025
Global Bioenergies Enters Receivership

Receivership aims to continue operations and preserve jobs. Four asset offers are pending. Without a final offer, liquidation and delisting will follow. Hearing set for 03 November 2025.